Sski
1 g/mL · Solution
- Prescription only
- Active substance
- Potassium Iodide
- Made by
- ATLANTIC BIOLOGICALS CORP.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
At a glance
Quoted from the official label · 2025-05-28
- SSKI ® (potassium iodide oral solution, USP) is for use as an expectorant in the symptomatic treatment of chronic pulmonary diseases where tenacious mucus complicates the problem, including bronchial asthma,…
Adults 0.3 ml (300 mg) or 0.6 ml (600 mg) diluted in one glassful of water, fruit juice or milk 3 to 4 times daily. To minimize gastric irritation, take with food or milk. This medication should be used no longer than necessary to produce the desired effect.
Full directions ↓- Prescription only
- FDA enforcement reports list no ongoing recall, and none from the last two years, for this product code · checked 2026-10-02
Every line above is selected, not written, from the official label. Nothing is reworded. DailyMed
What it is for
- SSKI ® (potassium iodide oral solution, USP) is for use as an expectorant in the symptomatic treatment of chronic pulmonary diseases where tenacious mucus complicates the problem, including bronchial asthma, bronchitis and pulmonary emphysema.
From the official label · 2025-05-28 · DailyMed
How it works
From this product’s own US prescribing label.
Potassium iodide is thought to act as an expectorant by increasing respiratory tract secretions and thereby decreasing the viscosity of mucus.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-05-28
Do not take it if
Contraindicated in patients with a known sensitivity to iodides.
Quoted from the official label, section “Contraindications”.
How to take it
These directions are for this exact strength and form. Another one is different.
Adults 0.3 ml (300 mg) or 0.6 ml (600 mg) diluted in one glassful of water, fruit juice or milk 3 to 4 times daily. To minimize gastric irritation, take with food or milk. This medication should be used no longer than necessary to produce the desired effect.
Quoted from the official label, section “Dosage & Administration”.
Other warnings
- Potassium iodide can cause fetal harm, abnormal thyroid function, and goiter when administered to a pregnant woman.
- Because of the possible development of fetal goiter, if the drug is used during pregnancy or if the patient becomes pregnant during therapy, apprise the patient of the potential hazard.
- General In some patients, prolonged use of iodides can lead to hypothyroidism.
- Iodides should be used with caution in patients having Addison's disease, cardiac disease, hyperthyroidism, myotonia congenita, tuberculosis, acute bronchitis, or renal function impairment.
- Drug Interactions Concurrent use with lithium or antithyroid drugs may potentiate the hypothyroid and goitrogenic effects of these medications.
- Drug/Laboratory Test Interactions Thyroid function tests may be altered by iodide.
- Pregnancy see " Warnings " section.
- Nursing Mothers Potassium iodide is excreted in breast milk.
- Pediatric Use Safety and effectiveness in children have not been established.
- General In some patients, prolonged use of iodides can lead to hypothyroidism.
- Iodides should be used with caution in patients having Addison's disease, cardiac disease, hyperthyroidism, myotonia congenita, tuberculosis, acute bronchitis, or renal function impairment.
Quoted from the official label, section “Warnings”.
Pregnancy and breastfeeding
- see " Warnings " section.
- Potassium iodide is excreted in breast milk. Use by nursing mothers may cause skin rash and thyroid suppression in the infant.
Quoted from the official label, section “OTC — Pregnancy or Breast Feeding”.
Other medicines
- Concurrent use with lithium or antithyroid drugs may potentiate the hypothyroid and goitrogenic effects of these medications.
- Concurrent use with potassium-containing medications, potassium-sparing diuretics and angiotensin-converting enzyme inhibitors (ACE inhibitors) may result in hyperkalemia and cardiac arrhythmias or cardiac arrest.
Quoted from the official label, section “Drug Interactions”.
If you take too much
In an emergency, call your local emergency number or a poison control centre.
- Acute toxicity from potassium iodide is relatively rare.
- An occasional individual may show marked sensitivity and the onset of acute poisoning can occur immediately or hours after administration.
- Angioedema, laryngeal edema and cutaneous hemorrhages may occur.
- Iodism or chronic iodine poisoning may occur during prolonged treatment or with the use of high doses.
- Symptoms of iodism typically disappear soon after discontinuation of the drug.
- Abundant fluid and salt intake aids in iodide elimination.
Quoted from the official label, section “Overdosage”.
Use in children
Safety and effectiveness in children have not been established.
Quoted from the official label, section “Pediatric Use”.
Side effects
- The most frequent adverse reactions to potassium iodide are stomach upset, diarrhea, nausea, vomiting, stomach pain, skin rash, and salivary gland swelling or tenderness.
- Less frequent adverse reactions include gastrointestinal bleeding, confusion, irregular heartbeat, numbness, tingling, pain or weakness in hands or feet, unusual tiredness, weakness or heaviness of legs, fever, and swelling of neck or throat.
- Thyroid adenoma, goiter, and myxedema are possible side effects.
- Iodism or chronic iodine poisoning may occur during prolonged treatment or with the use of high doses.
- The symptoms of iodism include burning of mouth or throat, severe headache, metallic taste, soreness of teeth and gums, symptoms of head cold, irritation of the eyes with swelling of the eyelids, unusual increase in salivation, acneform skin lesions in the seborrheic areas, and rarely, severe skin eruptions.
- If symptoms of iodism appear, the drug should be withdrawn and the patient given appropriate supportive therapy.
- Hypersensitivity to iodides may occur and may be manifested by angioedema, cutaneous and mucosal hemorrhage, and signs and symptoms resembling serum sickness, such as fever, arthralgia, lymph node enlargement, and eosinophilia.
Quoted from the official label, section “Adverse Reactions”.
What it looks like and how it is packed
- NDC 17856-0114-01 (potassium iodide oral solution, USP) is supplied in 0.1G/0.1mL 120 Syringes Inactive ingredient:
- Sodium thiosulfate as a preservative.
- Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].
- Keep tightly closed and protected from light.
- For the 237mL bottle, dispense in tight, light-resistant containers with child-resistant closures.
- For the 30mL bottle, place the child-resistant cap back on the amber glass bottle after using the clear plastic dropper for dispensing.
- Notice:
- When exposed to cold temperatures, crystallization may occur, but on warming and shaking, the crystals will redissolve.
- If the solution turns brownish-yellow in color, it should be discarded.
Quoted from the official label, section “How Supplied”.
How to store it
- Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].
- Keep tightly closed and protected from light.
- For the 237mL bottle, dispense in tight, light-resistant containers with child-resistant closures.
- For the 30mL bottle, place the child-resistant cap back on the amber glass bottle after using the clear plastic dropper for dispensing.
- Notice:
- When exposed to cold temperatures, crystallization may occur, but on warming and shaking, the crystals will redissolve.
- If the solution turns brownish-yellow in color, it should be discarded.
Quoted from the official label, section “Storage and Handling”.
What is in it
SSKI ® (potassium iodide oral solution, USP) is a saturated solution of potassium iodide containing 1 gram of potassium iodide per mL.
Quoted from the official label, section “Description”.
Ingredients people check for
Lactose, gluten, dyes, sugars and other ingredients that matter with an allergy, intolerance or diet — as this product’s FDA label lists them.
The stored label for this product has no list of inactive ingredients. The list on the pack is the one to check.
Quoted from the FDA label. A label that does not name an ingredient is not a guarantee that the product is free of it, and formulations change. With an allergy, check the pack and ask a pharmacist.
Every version of this medicine (5)
The same active substance, strength and kind of form, from every company that sells it — with what each label lists.
Showing 5 of 5
- SskiThis onePrescription onlyATLANTIC BIOLOGICALS CORP.No ingredient list on the stored label
- SskiPrescription onlyAvondale Pharmaceuticals, LLCNo ingredient list on the stored label
- Potassium IodidePrescription onlyBryant Ranch PrepackNo ingredient list on the stored label
- Potassium Iodide (saturated)Prescription onlyEmerald Therapeutics, LLCNo ingredient list on the stored label
- Potassium IodidePrescription onlyNivagen Pharmaceuticals, Inc.No ingredient list on the stored label
Details
| Made by | ATLANTIC BIOLOGICALS CORP. |
|---|---|
| Active substance | Potassium Iodide |
| Strength | 1 g/mL |
| Form | Solution |
| Route | Oral |
| Packs | 120 SYRINGE in 1 BOX, UNIT-DOSE / .1 mL in 1 SYRINGE |
| NDC | 17856-0114 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Solution2 products
1 g/mL2
1 g/mL · 2 companies
- ATLANTIC BIOLOGICALS CORP. · this page
- Avondale Pharmaceuticals, LLC
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.